Form 4: Soluna Holdings Director Thomas J. Marusak Receives Restricted Stock Awards
SEC Form 4 Filing
Director Thomas J. Marusak of Soluna Holdings, Inc. was granted 5,981 restricted stock awards on June 1, 2024, as part of his compensation.
Summary
- Thomas J. Marusak, a director of Soluna Holdings, Inc., received 5,981 restricted stock awards on June 1, 2024.
- These shares will vest in three tranches: 33% on June 1, 2024, 33% on June 1, 2025, and 34% on June 1, 2026.
- Vesting is contingent upon Marusak's continued service with Soluna Holdings on each vesting date.
- The transaction was approved by the Compensation Committee.
Sentiment
Score: 7
Explanation: The document reflects a standard compensation practice, indicating stability and alignment of interests. It's a neutral event with a slightly positive implication for corporate governance.
Positives
- The grant of restricted stock awards aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.
Industry Context
Equity compensation is a common practice in publicly traded companies to attract and retain key personnel, aligning their interests with those of shareholders.
Stakeholder Impact
- Shareholders may view the equity grant as a positive sign, aligning management's interests with long-term company performance.
Key Dates
| Date | Description |
|---|---|
| 06/01/2024 | Date of the transaction (grant of restricted stock awards) and first vesting date (33%). |
| 06/01/2025 | Second vesting date (33%). |
| 06/01/2026 | Third vesting date (34%). |
| 06/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.